You are here:

Archived: cefuroxime sodium (Aprokam)

Advice

in the absence of a submission from the holder of the marketing authorisation:

cefuroxime sodium (Aprokam®) is not recommended for use within NHS Scotland.

Indication under review: Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.
 

Drug Details

Drug Name: cefuroxime sodium (Aprokam)
SMC Drug ID: 932/13
Manufacturer: Spectrum Thea Pharmaceuticals Limited
Indication: Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery.
BNF Category:
Sub Category: 5.1 Antibacterial drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 9 December 2013

Current Advice

Abbreviated Submission 12 December 2016

Back